304 related articles for article (PubMed ID: 26200258)
1. Pathological differences between white and grey matter multiple sclerosis lesions.
Prins M; Schul E; Geurts J; van der Valk P; Drukarch B; van Dam AM
Ann N Y Acad Sci; 2015 Sep; 1351():99-113. PubMed ID: 26200258
[TBL] [Abstract][Full Text] [Related]
2. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
[TBL] [Abstract][Full Text] [Related]
3. Exploring the origins of grey matter damage in multiple sclerosis.
Calabrese M; Magliozzi R; Ciccarelli O; Geurts JJ; Reynolds R; Martin R
Nat Rev Neurosci; 2015 Mar; 16(3):147-58. PubMed ID: 25697158
[TBL] [Abstract][Full Text] [Related]
4. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
[TBL] [Abstract][Full Text] [Related]
5. [Cortical gray matter lesions in multiple sclerosis].
Kawachi I; Nishizawa M
Brain Nerve; 2015 Apr; 67(4):497-504. PubMed ID: 25846598
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.
Espitia Pinzon N; Stroo E; 't Hart BA; Bol JG; Drukarch B; Bauer J; van Dam AM
PLoS One; 2014; 9(6):e100574. PubMed ID: 24959868
[TBL] [Abstract][Full Text] [Related]
7. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
Loveless S; Neal JW; Howell OW; Harding KE; Sarkies P; Evans R; Bevan RJ; Hakobyan S; Harris CL; Robertson NP; Morgan BP
Brain Pathol; 2018 Jul; 28(4):507-520. PubMed ID: 28707765
[TBL] [Abstract][Full Text] [Related]
9. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
[TBL] [Abstract][Full Text] [Related]
10. Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.
Prins M; Dutta R; Baselmans B; Brevé JJ; Bol JG; Deckard SA; van der Valk P; Amor S; Trapp BD; de Vries HE; Drukarch B; van Dam AM
Acta Neuropathol Commun; 2014 Aug; 2():98. PubMed ID: 25149422
[TBL] [Abstract][Full Text] [Related]
11. The Application of Consensus Weighted Gene Co-expression Network Analysis to Comparative Transcriptome Meta-Datasets of Multiple Sclerosis in Gray and White Matter.
Chai K; Zhang X; Tang H; Gu H; Ye W; Wang G; Chen S; Wan F; Liang J; Shen D
Front Neurol; 2022; 13():807349. PubMed ID: 35280300
[TBL] [Abstract][Full Text] [Related]
12. Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures.
Tripathi A; Pandit I; Perles A; Zhou Y; Cheng F; Dutta R
Ann Clin Transl Neurol; 2021 Jun; 8(6):1279-1291. PubMed ID: 33978322
[TBL] [Abstract][Full Text] [Related]
13. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
Kutzelnigg A; Lassmann H
Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
[TBL] [Abstract][Full Text] [Related]
14. White matter and subcortical gray matter lesion volume changes and late-life depression outcome: a 4-year magnetic resonance imaging study.
Chen PS; McQuoid DR; Payne ME; Steffens DC
Int Psychogeriatr; 2006 Sep; 18(3):445-56. PubMed ID: 16478567
[TBL] [Abstract][Full Text] [Related]
15. [Gray matter lesions and cognitive impairment in multiple sclerosis].
Kawachi I; Saji E; Nishizawa M
Rinsho Shinkeigaku; 2014; 54(12):1060-2. PubMed ID: 25672709
[TBL] [Abstract][Full Text] [Related]
16. Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis.
Smolders J; Fransen NL; Hsiao CC; Hamann J; Huitinga I
Expert Rev Neurother; 2020 Aug; 20(8):835-848. PubMed ID: 32476499
[TBL] [Abstract][Full Text] [Related]
17. Comparative Proteomic Profiling Identifies Reciprocal Expression of Mitochondrial Proteins Between White and Gray Matter Lesions From Multiple Sclerosis Brains.
Rai NK; Singh V; Li L; Willard B; Tripathi A; Dutta R
Front Neurol; 2021; 12():779003. PubMed ID: 35002930
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Haider L; Simeonidou C; Steinberger G; Hametner S; Grigoriadis N; Deretzi G; Kovacs GG; Kutzelnigg A; Lassmann H; Frischer JM
J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1386-95. PubMed ID: 24899728
[TBL] [Abstract][Full Text] [Related]
19. The histopathology of grey matter demyelination in multiple sclerosis.
Bø L
Acta Neurol Scand Suppl; 2009; (189):51-7. PubMed ID: 19566500
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
